Navigation Links
Regeneron Submits Biologics License Application to FDA for VEGF Trap-Eye for Treatment of Wet Age-Related Macular Degeneration
Date:2/22/2011

sruption and dysfunction of the retina creating distortion and/or blind spots in central vision, and it can account for blindness in wet AMD patients.  Wet AMD is the leading cause of blindness for people over the age of 65 in the U.S. and Europe.  It is estimated that more than 210,000 Americans are newly diagnosed with and treated for wet AMD each year.

About Central Retinal Vein Occlusion (CRVO)Over 100,000 people in the United States and more than 66,000 people in key European countries are estimated to suffer from central retinal vein occlusion (CRVO).  CRVO is caused by obstruction of the central retinal vein that leads to a back up of blood and fluid in the retina.  This causes retinal injury and loss of vision.  The retina can also become "ischemic" (starved for oxygen), resulting in the growth of new, inappropriate blood vessels that can cause further vision loss and more serious complications.  Release of vascular endothelial growth factor (VEGF) contributes to increased vascular permeability in the eye and inappropriate new vessel growth.  It is believed that anti-VEGF treatment may help decrease vascular permeability and edema and prevent the inappropriate growth of new blood vessels in the retina in patients with CRVO.

About Diabetic Macular Edema (DME)Diabetic macular edema (DME) is the most prevalent cause of moderate vision loss in patients with diabetes.  DME is a common complication of Diabetic Retinopathy (DR), a disease affecting the blood vessels of the retina.  Clinically significant DME is a leading cause of blindness in younger adults (under 50).  Clinically significant DME occurs when fluid leaks into the center of the macula, the light-sensitive part of the retina responsible for sharp, direct vision.  Fluid in the macula can cause severe vision loss or blindness.

Approximately 370,000 Americans currently suffer from clinically significant DME, with 95,
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
2. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
3. Enrollment Completed in Regeneron and Bayer HealthCare Phase 3 Studies of VEGF Trap-Eye in Neovascular Age-Related Macular Degeneration (Wet AMD)
4. Regeneron Announces Presentation at the 18th Annual Credit Suisse Healthcare Conference
5. Regeneron Reports Third Quarter 2009 Financial and Operating Results
6. Sanofi-aventis and Regeneron Expand Strategic Antibody Collaboration
7. Regeneron Announces Presentation at the Deutsche Bank 2009 Biotech Boston Confab
8. BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark
9. Regeneron Announces Presentation at the Morgan Stanley Global Healthcare Conference
10. Regeneron Announces Presentation at the UBS Global Life Sciences Conference
11. Regeneron Announces Panel Discussion at Citis 5th Annual Biotech Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... Pharma Major Lupin Limited today announced the acquisition of ... subject to certain closing conditions. The acquisition marks ... 765 billion in sales, placing it as one of the ... Health). For over a decade, Russian pharmaceutical market recorded double ... Russia to be one of the ...
(Date:7/2/2015)... , July 2, 2015  Konica Minolta, Inc. (Konica ... that it has acquired Sawae Technologica Ltda., an X-ray ... Brazil , through its Brazilian healthcare sales company, ... Local Brazil market ... increasing population exceeding 200 million, significant healthcare technical advancements ...
(Date:7/2/2015)... , South Korea, July 2, 2015 ALPINION MEDICAL ... new E-CUBE Series ultrasound system. Developed to enhance user ... areas, the E-CUBE 15 EX produces superb image quality. ... performance in women,s health, general imaging, and shared service ... The latest in the renowned E-CUBE Series, the E-CUBE ...
Breaking Medicine Technology:Lupin Acquires Biocom in Russia 2Lupin Acquires Biocom in Russia 3Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 2Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 3E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care 2E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care 3
... Inc. (OTC Bulletin Board: CGNH), developer of the ultra-sensitive QL Care™ Point-Of-Care (POC) ... that the Company,s ticker symbol has been changed back to "CGNH" and the ... , , ... , , ...
... , July 22 Charter Business customers in Wisconsin ... program for rural health care that the Federal Communications Commission (FCC) proposes ... , , ... FCC last week would make permanent the Rural Health Care Pilot Program, ...
Cached Medicine Technology:CardioGenics Holdings Inc. Receives New Ticker Symbol 2Charter's Wisconsin, Oregon Customers Already Benefiting From FCC's Efforts to Expand Medical Services via Broadband 2Charter's Wisconsin, Oregon Customers Already Benefiting From FCC's Efforts to Expand Medical Services via Broadband 3Charter's Wisconsin, Oregon Customers Already Benefiting From FCC's Efforts to Expand Medical Services via Broadband 4
(Date:7/2/2015)... ... July 02, 2015 , ... ... providers, has been retained to lead a national chief operating officer recruitment ... search firms in the healthcare industry, B. E. Smith has recently placed more ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... ... overall status of the Gelatin Capsule manufacturers. The report is a valuable source ... The report depicts the global and Chinese market for the Gelatin Capsule industry ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... solutions for drugs, biologics and consumer health products, today announced that it has ... Irmgard Neuper is the new General Manager at Catalent’s Schorndorf facility, which provides ...
(Date:7/2/2015)... ... July 02, 2015 , ... Today, East Liverpool City Hospital ... Center at East Liverpool City Hospital (ELCH). Pam is currently the Chief Nursing Officer ... director of surgery. Pam holds a master’s degree in health care administration as well ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... Garramone introduced CoolSculpting Plus, an advanced approach to body contouring. CoolSculpting ... to 44%. , About the basic CoolSculpting procedure:, The CoolSculpting procedure ...
Breaking Medicine News(10 mins):Health News:Nicklaus Children’s Hospital Retains B. E. Smith to Recruit New Chief Operating Officer 2Health News:Nicklaus Children’s Hospital Retains B. E. Smith to Recruit New Chief Operating Officer 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 2Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 4Health News:Catalent Makes Two Key European Appointments in Oral Dose Manufacturing 2Health News:East Liverpool City Hospital Announces New Surgical Center Leadership 2Health News:East Liverpool City Hospital Announces New Surgical Center Leadership 3Health News:Fort Myers Plastic Surgeon Introduces a New and Improved Body Contouring Procedure - CoolSculpting Plus™ 2Health News:Fort Myers Plastic Surgeon Introduces a New and Improved Body Contouring Procedure - CoolSculpting Plus™ 3Health News:Fort Myers Plastic Surgeon Introduces a New and Improved Body Contouring Procedure - CoolSculpting Plus™ 4
... Muscles usually contract when a neurotransmitter molecule is released ... Utah scientists discovered that bare subatomic protons can act ... in tiny round worms so the worms can poop. ... neurotransmitters to trigger electrical changes in cells. Protons are ...
... Free-of-charge expertise for factories in Bangladesh, Kenya, Tanzania and ... ... Jan. 9 Roche today announced that it has,entered into four ... where improvements in access to,anti-retroviral therapy are needed. These companies are ...
... Jerusalem, Jan. 9. 2008 -- Two Hebrew University of ... have been awarded the 2008 Wolf Prize in Medicine ... expression and cancer research. , Minister of Education ... announced that the $100,000 prize, often referred to as ...
... syndrome and lead to new treatments , , WEDNESDAY, ... syndrome anticipate and react to pain differently than women ... University of California, Los Angeles researchers found that women ... mechanism in the brain, which makes them more sensitive ...
... Draws On Strategic Intelligence and Competitive Analysis Information ... From Newport Horizon ... of The Thomson Corporation (NYSE: TOC ; TSX: TOC) ... communities, has released the first issue of Movers and Shakers.,This ...
... A. Woertz Appointed to Board of Directors, ... Gamble,Company (NYSE: PG ) today announced the ... executive officer of Archer Daniels Midland,Corporation (NYSE: ... effective,immediately., (Photo: http://www.newscom.com/cgi-bin/prnh/20080108/CLTU115-a ), ...
Cached Medicine News:Health News:Proton-powered pooping 2Health News:Proton-powered pooping 3Health News:Proton-powered pooping 4Health News:Roche Engages in Four Additional AIDS Technology Transfers to Strengthen Local Manufacturing in World's Poorest Countries 2Health News:Roche Engages in Four Additional AIDS Technology Transfers to Strengthen Local Manufacturing in World's Poorest Countries 3Health News:Roche Engages in Four Additional AIDS Technology Transfers to Strengthen Local Manufacturing in World's Poorest Countries 4Health News:2 Hebrew University scientists awarded Wolf Prizes 2Health News:Women With IBS Unable to Switch Off Pain Response 2Health News:Thomson Scientific Introduces a New Quarterly Report Identifying the 'Movers and Shakers' in the U.S. Generics Industry 2Health News:Thomson Scientific Introduces a New Quarterly Report Identifying the 'Movers and Shakers' in the U.S. Generics Industry 3Health News:Thomson Scientific Introduces a New Quarterly Report Identifying the 'Movers and Shakers' in the U.S. Generics Industry 4Health News:Procter & Gamble Announces Appointment of Director 2
... Fibrin Sealant has been shown to be ... Containing uniform, reproducible concentrations of fibrinogen and ... final stage of the coagulation cascade to ... firmly adheres to connective tissue like a ...
... catheter is inserted into the subclavian or ... vena cava. The Cool Line incorporates ... temperature-controlled saline flowing within a closed-loop design, ... circulation. The Cool Line combines two ...
... The Fortius catheter provides maximum ... to target temperature. The Fortius catheter ... design to provide the ultimate solution ... catheter is inserted percutaneously into the ...
...
Medicine Products: